Article in Addiction science & clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
3 authors.
Angela R BazziHerbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. abazzi@health.ucsd.edu.
Hansel E TookesDepartment of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Tyler S BartholomewDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Funding
Efficacy of a community-based PrEP uptake intervention for people who inject drugs in the US NortheastR01DA051849 · NIDA · BROWN UNIVERSITY · PI BAZZI, ANGELA ROBERTSON, BIELLO, KATIE BROOKS · 2020 to 2024
$3.7M
SAIA-PrEP: a systems analysis and improvement approach to optimize PrEP implementation in syringe service programsR01DA056883 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON, LAMBDIN, BARROT HOPKINS · 2022 to 2025
$3.4M
In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-health concierge for people who inject drugsR01DA058352 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Joshua Adam Barocas, Tyler Scott Bartholomew · 2023 to 2026
$2.7M
Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People who Inject Drugs: a Randomized Controlled TrialDP2DA053720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TOOKES, HANSEL EMORY · 2021 to 2024
$2.6M
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infectionR01DA058437 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Adam Wayne Carrico, Mario Stevenson · 2023 to 2026
$2.6M
Project ACCESS: Advancing Equitable Access to HIV/HCV Testing Through Structural Transformation in Syringe Services Programs: A Cluster Randomized TrialR01DA060462 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Tyler Scott Bartholomew, Hansel Emory Tookes · 2024 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Advancing pre-exposure prophylaxis (PrEP) implementation for people who use drugs: an introduction to and lessons from the special series. · full record | OpenQuestion